Inspired by Mayo Clinic’s history of collaboration, we work with biopharma, diagnostic, and other biotech companies to break down barriers to change medicine. We bring Mayo Clinic expertise and quality to each project — offering a wide range of laboratory testing to support all phases of your clinical trials. Together we have the power to improve global health.
4,400
4,400 LABORATORY AND PATHOLOGY TESTS SPANNING ALL MEDICAL SUBSPECIALTIES
4,500
4,500 physicians and scientists
60+
60+ laboratories under CAP/CLIA with dedicated directors and development technologists
“We take everything we know about diagnostics and their use for the patient, and bring in innovative new tools into that environment, at a level of quality and consistency to produce the best possible data for biopharma customers.”
William Morice, II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories
Our difference
The latest
Mayo Clinic Laboratories is excited to participate in the 65th ASH Annual Meeting & Exposition, which will take place in San Diego on Dec. 9–12, 2023.
Together, Mayo Clinic Laboratories and Helix will provide biopharma customers with a full spectrum of testing capabilities and end-to-end laboratory testing support.
The MayoComplete Liquid Biopsy Panel offers a noninvasive alternative to traditional cell-based biopsies. This allow for faster turnaround time and the ability to perform molecular DNA testing in cancer patients where tumor tissue isn’t available.